CGON

CG Oncology Inc
Health CareUSCUSIP 156944100◍ Confluence graph
Tracked 13F Holders
205
-121 QoQ
13F Value (tracked)
$5.2B
Insider Net · 180d
$20.7M
1↑ 2↓
Recent Filings
15
Smart-money sentimentBullish
BearishBullish
13F funds (latest Q)29 adding · 26 trimming
Insider net (180d)+$20.7M

Who owns CGON?

205 tracked 13F filers

205 tracked 13F filers disclose a position in CGON as of the latest SEC 13F filings, a combined $5.2B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

All quarters use one ordinary-share-equivalent series. Historical ADS are converted at 2 ADS = 1 ordinary share. Expand a row for the exact calculation; the residual is not classified as a trade.
2 source-reported value rows are withheld because the reported units do not agree with same-security peers. Share counts remain visible and unchanged.
#FundPosition valueSharesLast moveAs ofHistory
1RTW INVESTMENTS, LP
$605.0M
8.5M
+22%
Added · +1.5M sh
Q2 2026
2T. Rowe Price Investment Management, Inc.
Withheld
6.7M
16×
Added · +6.3M sh
Q1 2026
3Decheng Capital LLC
$452.7M
6.4M
Held
Q2 2026
4BlackRock, Inc.
$342.7M
5.1M
+4.6%
Added · +221K sh
Q1 2026
5FMR LLC
$254.8M
3.8M
−12%
Reduced · −533K sh
Q1 2026
6TCG Crossover Management, LLC
$248.4M
3.7M
Held
Q1 2026
7PRICE T ROWE ASSOCIATES INC /MD/
$247.2M
3.7M
+6.1%
Added · +210K sh
Q1 2026
8STATE STREET CORP
$244.2M
3.4M
+30%
Added · +791K sh
Q2 2026
9VANGUARD PORTFOLIO MANAGEMENT LLC
$209.5M
3.1M
First observed position
No prior filed position
Q1 2026
10VANGUARD CAPITAL MANAGEMENT LLC
$205.3M
3.0M
First observed position
No prior filed position
Q1 2026
11Foresite Capital Management VI LLC
$150.3M
2.2M
Held
Q1 2026
12GEODE CAPITAL MANAGEMENT, LLC
$153.0M
2.2M
+35%
Added · +556K sh
Q2 2026
13FRANKLIN RESOURCES INC
$102.0M
1.5M
−3.5%
Reduced · −55K sh
Q1 2026
14BANK OF AMERICA CORP /DE/
$98.1M
1.4M
+22%
Added · +259K sh
Q1 2026
15DV Trading LLC
$97.4M
1.4M
Held
Q1 2026
16UBS Group AG
$88.8M
1.3M
−32%
Reduced · −612K sh
Q1 2026
17ALLIANCEBERNSTEIN L.P.
$53.6M
1.3M
−20%
Reduced · −323K sh
Q1 2026
18Avidity Partners Management LP
$87.2M
1.3M
−12%
Reduced · −184K sh
Q1 2026
19GOLDMAN SACHS GROUP INC
$78.5M
1.2M
−12%
Reduced · −165K sh
Q1 2026
20ACORN CAPITAL ADVISORS, LLC
$80.4M
1.1M
+0.1%
Added · +999 sh
Q2 2026
21EcoR1 Capital, LLC
$74.6M
1.1M
+43%
Added · +330K sh
Q1 2026
22UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME
$72.1M
1.1M
−2.4%
Reduced · −26K sh
Q1 2026
23Foresite Capital Management V, LLC
$68.0M
1.0M
Held
Q1 2026
24ORBIMED ADVISORS LLC
$64.2M
948K
−37%
Reduced · −568K sh
Q1 2026
25Jefferies Financial Group Inc.
$54.7M
770K
New
+770K sh
Q2 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is CGON being bought or sold by institutions?

Last quarter, 7 funds opened a new position in CGON and 22 added to an existing one, while 26 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened (NEW)
7
funds
Added
22
funds
Reduced
26
funds
Exited
0
funds

Funds that own CGON also own

CompanyCo-held byCombined value
MICROSOFT CORPMSFT101 funds$227.5B
AMAZON.COM INCAMZN101 funds$166.6B
NVIDIA CORPNVDA100 funds$339.7B
BROADCOM INCAVGO100 funds$135.9B
ELI LILLY & COLLY99 funds$68.0B
MICRON TECHNOLOGY INCMU99 funds$28.5B
UNITEDHEALTH GROUP INCUNH98 funds$22.6B
ADVANCED MICRO DEVICESAMD97 funds$29.7B
ALPHABET INC-CL AGOOGL95 funds$146.2B
META PLATFORMS INC-CLASS AMETA95 funds$98.0B
MERCK & CO. INC.MRK95 funds$23.5B
BOSTON SCIENTIFIC CORPBSX95 funds$11.6B

Ranked by how many of CGON's institutional holders also hold each name, a cross-fund conviction signal.

Insider activity (Form 4)

Full insider page →
Buys · 180d
$24.8M
1 insiders
Sells · 180d
$4.1M
2 insiders
Net
$20.7M
12 P/S txns
Signal
Net Buying
open-market
DateInsiderRoleActionSharesValue
Aug 14, 2026POST LEONARD EDirectorSell (S)1K$75K
Jul 15, 2026POST LEONARD EDirectorSell (S)1K$71K
Jul 10, 2026Mulay JamesDirectorSell (S)24K$1.8M
Jun 25, 2026Liu Brian Guan-ChyunDirectorBuy (P)371K$24.8M
Jun 24, 2026POST LEONARD EDirectorSell (S)5K$350K
Jun 22, 2026POST LEONARD EDirectorSell (S)5K$325K
Jun 15, 2026Mulay JamesDirectorSell (S)654$39K
Jun 15, 2026Mulay JamesDirectorSell (S)1K$79K
Jun 4, 2026POST LEONARD EDirectorSell (S)1K$55K
Apr 17, 2026Mulay JamesDirectorSell (S)16K$1.1M
Mar 16, 2026Mulay JamesDirectorSell (S)654$42K
Mar 16, 2026Mulay JamesDirectorSell (S)1K$83K

Institutional ownership over time

78 funds-13 since Q3 2024
0100199Q3 2024Q1 2025Q3 2025Q1 2026Q2 2026
funds holding aggregate valuelatest $1.3B · 1 values withheld

Recent filings

15 shown

Keep exploring

Connected entities for CGON

Browse more

Build

Ask your agent what changed in CGON

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/CGON/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for CGON.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for CGON. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.